Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

34.26
Delayed Data
As of Feb 24
 +0.20 / +0.59%
Today’s Change
28.74
Today|||52-Week Range
37.39
+5.48%
Year-to-Date
Details Still Missing on Republicans' 'Once in a Generation' Tax Plan
Feb 24 / TheStreet.com - Paid Partner Content
Manchester mulls paying for medicines based on their efficacy
Feb 24 / FT.com - Paid Partner Content
3 Biotech Long Shots: Boom Or Bust?
Feb 24 / MotleyFool.com - Paid Partner Content
Dow Jones Leads Market Gains on Thursday
Feb 23 / GuruFocus News - Paid Partner Content
Dow 30 Stock Roundup: Wal-Mart, Home Depot Beat on Earnings, Boeing Wins $1.32B Order...
Feb 24 / Zacks.com - Paid Partner Content
Why 3D Printing and Biotech Will Be Good Bets in 2017
Feb 23 / GuruFocus News - Paid Partner Content
SNS Financial Group, LLC Buys Pfizer, Facebook, C.H. ...
Feb 24 / GuruFocus News - Paid Partner Content
Better Cloud Growth Stock: Twilio Inc. vs. Veeva Systems
Feb 23 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: Is BMY the Next Acquisition Target? Priority Review for PFE, No...
Feb 24 / Zacks.com - Paid Partner Content
Clovis (CLVS) Q4 Loss Wider than Expected; Focus on Rubraca
Feb 23 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close34.06
Today’s open34.17
Day’s range33.99 - 34.35
Volume24,711,954
Average volume (3 months)27,308,245
Market cap$203.9B
Dividend yield3.74%
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+5.09%
Earnings growth (this year)+6.97%
Earnings growth (next 5 years)+5.90%
Revenue growth (last year)+8.13%
P/E ratio34.3
Price/Sales3.79
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MRKMerck+0.31+0.47%
NVSNovartis-0.17-0.22%
SNYSanofi+0.19+0.45%
GSKGlaxoSmithKline+0.07+0.17%
Data as of 4:02pm ET, 02/24/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)$0.67
Annual revenue (last year)$52.8B
Annual profit (last year)$7.2B
Net profit margin13.63%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts


Search for Jobs